Phase 3 Immunogenicity Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Influenza Vaccination Strategy for Patients With Hematologic Malignancy
Hematologic NeoplasmsInfluenzaImmunogenicity
Asan Medical Center60 enrolled1 locationNCT07485855
Recruiting
Phase 3
Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC
SafetyVaccinationChildren+3 more
Jean-Pierre Van geertruyden344 enrolled1 locationNCT06844487
Completed
Phase 3
Follow up of immunogenicity and safety of acellular pertussis vaccine given at birth to 4 years of age
Pertussis immunogenicity
The Sydney Children's Hospitals Network200 enrolled4 locationsACTRN12614001325695
Active
Phase 3
Preventing Invasive Pneumococcal Disease in Children & Adolescents with Leukaemia
Immunogenicity of pneumococcal vaccination in children and adolescents newly diagnosed with Leukaemia, with the aim to protect them from invasive pneumococcal disease
NHMRC CCRE in Childhood and Adolescent Immunisation100 enrolled1 locationACTRN12609000515291